Anticoagulation Management and Reversal

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (odpre novo okno)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Vir‎: World J Emerg Surg 2024;19(1):26.

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (odpre novo okno)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Vir‎: Lancet 2015;385(9982):2077-87.

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (odpre novo okno)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Vir‎: Anesth Analg 2011;113(4):703-10.

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (odpre novo okno)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Vir‎: World Neurosurg 2014;81(1):110-5.

Informacije za zdravnike

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (odpre novo okno)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (odpre novo okno)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (odpre novo okno)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (odpre novo okno)

Emergency reversal of warfarin anticoagulation. (odpre novo okno)

Management of anticoagulation agents in trauma patients. (odpre novo okno)

Idarucizumab for dabigatran reversal - full cohort analysis. (odpre novo okno)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (odpre novo okno)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (odpre novo okno)

Odbori za stike z bolnišnicami (OSB)

Paketi informacij za zdravnike

Videoposnetki

Anticoagulation Management and Reversal

Izberite svoj jezik